share_log

Entrada Therapeutics(TRDA.US) Director Buys US$35,289.8 in Common Stock

moomoo News ·  Apr 10 17:18

$Entrada Therapeutics (TRDA.US)$ Director KIM PETER S purchased 2,600 shares of common stock on Apr 8, 2024 at an average price of $13.573 for a total value of $35,289.8.

1712783881120064867.png

What is statement of changes in beneficial ownership of securities?

It is a requirement under federal securities laws that mandates individuals, including officers, directors, and those who hold more than 10% of any class of a company's securities (collectively known as "insiders"), to report their purchases, sales, and holdings of their company's securities by submitting Forms 3, 4, and 5.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment